| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |